WebOxular is committed to transforming the treatment paradigm for sight-threatening retinal disorders by providing safe, durable therapeutics that are precisely delivered to specific ocular tissues to control disease activity. We have…. Exceptional R&D capability and best-in-class technology. Near-term, high-value, differentiated product pipeline. WebMar 1, 2024 · Oxuspheres™ – A proprietary drug-containing biodegradable polymer system, designed as an adjustable, sustained release formulation, with the ability to provide up to 12 months’ treatment for retinal diseases following single administration. This has the potential to address significant unmet needs, thereby improving patient outcomes and ...
Oxular raises $37 million – Led by specialist life sciences investor ...
WebAug 29, 2024 · The OXUSPHERES is under the trademark classification: Pharmaceutical Products; Medical Instrument Products; The OXUSPHERES trademark covers Pharmaceutical and ophthalmic preparations and substances; pharmaceutical and ophthalmic preparations and substances for the prevention and treatment of retinal … WebOXUSPHERES is a trademark and brand of Oxular Limited. OXUSPHERES Trademark Information. Trademark by Oxular Limited. Pharmaceutical and ophthalmic preparations and substances; pharmaceutical and ophthalmic preparations and substances for the prevention and treatment of retinal diseases and disorders; drug delivery agents; microspheres; … scottsville ky to bowling green ky
Oxular Raises $37 Million - Medical Device News Magazine
WebOXUSPHERES: STANDARD CHARACTERS: YES: USPTO-GENERATED IMAGE: YES: LITERAL ELEMENT: OXUSPHERES: MARK STATEMENT: The mark consists of standard characters, without claim to any particular font style, size, or color. REGISTER: Principal: APPLICANT INFORMATION *OWNER OF MARK: Oxular Limited *MAILING ADDRESS: Magdalen Centre … WebMar 1, 2024 · · Oxuspheres™ – A proprietary drug-containing biodegradable polymer system, designed as an adjustable, sustained release formulation, with the ability to provide up to 12 months’ treatment for retinal diseases following single administration. WebJan 24, 2024 · OXU-001 is dexamethasone formulated in a novel biodegradable drug preparation known as Oxuspheres ®. OXU-001 will be delivered to the posterior suprachoroidal space of the eye via Oxulumis ®,... scottsville ky to nashville airport